Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KDM5A | P29375 | 1/20 | 0.47 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | APLNR | P35414 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16098758 | 0.87 | USP2 (0.44) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL1983234 | 0.82 | MEN1 (0.43) | ALDH1A1MEN1KMT2AKDM4ENPC1 | |
| SCHEMBL6422773 | 0.82 | MEN1 (0.44) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL1033018 | 0.80 | KDM5A (0.53) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL16029767 | 0.80 | MAP3K5 (0.60) | MAPTSMN1; SMN2MEN1POLBKMT2A | |
| SCHEMBL8322185 | 0.76 | MAPT (0.49) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL321963 | 0.75 | KDM5A (0.54) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL8320986 | 0.74 | MAPT (0.46) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL7754979 | 0.74 | KDM5A (0.53) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL7754982 | 0.73 | KDM5A (0.52) | LMNAALDH1A1MAPTSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970129-A2 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2016-01-20 | — | — | EP | claimed |
| WO-2014153145-A2 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2014-09-25 | — | — | WO | claimed |
| EP-2970129-A2 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014153145-A2 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2014-09-25 | — | — | WO | disclosed |
| EP-2337779-A2 | 2-OXO-1,2-DIHYDRO-QUINOLINE MODULATORS OF IMMUNE FUNCTION | Teva Pharmaceutical Industries Ltd. (IL) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010028015-A2 | 2-OXO-1,2-DIHYDRO-QUINOLINE MODULATORS OF IMMUNE FUNCTION | AUSPEX PHARMACEUTICALS, INC (US) | 2010-03-11 | — | — | WO | disclosed |